Welcome to our dedicated page for F5 SEC filings (Ticker: FFIV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
F5’s shift from hardware appliances to subscription-driven security software leaves investors hunting through dense disclosures to track recurring revenue, deferred contracts, and escalating R&D. Add in patent cases and multi-cloud buzzwords, and the paperwork quickly stretches past 250 pages. If finding the ADC segment margin or the latest NGINX growth rate inside a single 10-K feels impossible, you’re not alone.
Stock Titan resolves that problem. Our AI distills every F5 quarterly earnings report 10-Q filing, flags F5 8-K material events explained, and translates footnotes into plain English. Want immediate alerts on F5 insider trading Form 4 transactions? We stream F5 Form 4 insider transactions real-time so you can spot executive moves before the market digests them. Each document—whether an F5 annual report 10-K simplified or the latest F5 proxy statement executive compensation—is paired with concise, AI-powered summaries that highlight subscription growth, hardware backlog, cybersecurity risks, and stock-based compensation shifts.
Practical results follow:
- Compare software vs. hardware revenue trends without scrolling hundreds of pages.
- Monitor F5 executive stock transactions Form 4 alongside upcoming product releases.
- Run an F5 earnings report filing analysis that pulls key metrics in seconds.
Whether you’re understanding F5 SEC documents with AI for a quick trade idea or building a long-term thesis around cloud security demand, Stock Titan delivers every form, every footnote, in real time—F5 SEC filings explained simply.
Chad Michael Whalen, EVP Worldwide Sales of F5, Inc. (FFIV), reported multiple open-market sales executed under a Rule 10b5-1 trading plan dated April 30, 2025. The filing shows four sales on 08/11/2025 totaling 5,297 shares, with weighted-average sale prices running from $320.24 to $323.07 per share.
Those entries in Table I show the reporting person’s direct beneficial ownership declining across the transactions to a reported holding of 23,591 shares following the sales. The filing notes the transactions were made pursuant to the pre-established 10b5-1 plan and provides weighted-price ranges for transparency.
F5, Inc. filed a Form 144 notice indicating a proposed sale of 5,297 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/11/2025. The filing lists an aggregate market value of $1,706,874.03 and shows 57,447,170 shares outstanding, indicating the proposed sale is a small portion of the company's total shares.
The shares were acquired as restricted stock from the issuer on 08/01/2018 and payment is recorded as on that date. The filer reports no securities sold in the past three months and makes the standard representation that they do not possess undisclosed material information; the filing references Rule 10b5-1 language but does not provide a plan adoption date.
FFIV Q3 FY25 (quarter ended 30 Jun 2025) snapshot:
- Revenue $780.4 m, +12% YoY; product $388.8 m (+26%), services $391.5 m (+1%).
- Gross margin 81.0% (+60 bp); operating margin 25.2% (+180 bp).
- Net income $189.9 m (+32%); diluted EPS $3.25 (+33%).
- Nine-month operating cash flow $741.6 m; cash & investments $1.43 bn (up $359 m since 9/24); no debt after $350 m revolver expired 1/31/25.
- Deferred revenue grew to $1.96 bn (+9% vs 9/24); RPO $2.0 bn with 61% due within 12 months.
- Share buy-backs: 0.49 m shares for $125 m; $1.05 bn capacity remains.
- Systems revenue rebounded (+39%) and now 46.5% of product mix; software +16%.
- OpEx +10% YoY (R&D +10%, G&A +19%); FY25 YTD restructuring charges $11.3 m.
- Effective tax rate fell to 10.8% (vs 16.0%); diluted share count -1.1% YoY.
Balance sheet strong: assets $6.11 bn, long-term liabilities $1.09 bn, equity $3.47 bn. Two immaterial acquisitions added $12 m goodwill; no impairment or credit issues disclosed.
FAQ
What is the current stock price of F5 (FFIV)?
What is the market cap of F5 (FFIV)?
